Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HIMA

This article was originally published in The Gray Sheet

Executive Summary

Adds former HHS staffers Susan Zagame and Anna Baldwin to its Technology and Regulatory Affairs Department. Zagame was named director, regulatory affairs and counsel; Baldwin will be director, technical and regulatory affairs. Prior to joining the Health Industry Manufacturers Association, Zagame served as acting HHS general counsel, a post she assumed in November 1992 following the departure of Michael Astrue. She was appointed HHS deputy general counsel in May 1989. Baldwin most recently served as a policy analyst in FDA's Office of the Commissioner

Latest Headlines
See All
UsernamePublicRestriction

Register

MT001665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel